US 5,314,909 AGranted

Use of non-steroidal antiiflammatory agents in macular degeneration

AssigneeMerck & Co., Inc.

InventorJens Dollerup

Life of this patent

Estimating the term…

Abstract

Topically applied non-steroidal antiinflammatory agents (NSAID's) are useful in the treatment of macular degeneration.

Claims3

Dependent claims

A method of treating macular degeneration which comprises the topical ocular administration to a patient in need of such treatment of an effective amount of an NSAID.

Dependencies are inferred from the claim text.

Facts

Application: 08/032,366Filed 17 Mar 1993
Granted: 24 May 1994
Term ends: Not estimatedThe source records don’t support an estimate.

Classification5 codes

A61K 31/40
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having five-membered rings with one nitrogen as the only ring hetero atom,…
A61K 31/19
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids: carboxylic acids, e.g. valproic acid
A61K 31/195
Carboxylic acids, e.g. valproic acid: having an amino group
A61K 31/405
Indoles, e.g. pindolol: indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…